Product catalogue
Every compound held in the RSSE catalogue, with its CAS number, molecular formula and structure where available. Certificate of analysis issued per lot; quoted per enquiry.
484,173 products · 8070 pages
Products in this list
-
Mannose Impurity 30
CUSTOM SYNTHESIS -
Mosapride
IN STOCK -
Methylergometrine
IN STOCK -
5-Amino-3-methyl-1-phenylpyrazole
IN STOCK -
Moxidectin
IN STOCK -
Medetomidine
CUSTOM SYNTHESIS -
Mirogabalin
IN STOCK -
Mirogabalin Enantiomer
IN STOCK -
Mirogabalin Besylate
IN STOCK -
Montelukast Sulfoxide
IN STOCK -
Bisoprolol Impurity 65
IN STOCK -
Marbofloxacin
IN STOCK -
3-methyltetrahydrofuran-3-amine
CUSTOM SYNTHESIS -
Memantine Lactose Adduct
CUSTOM SYNTHESIS -
Piracetam Impurity 31
IN STOCK -
Methyl dichloroacetate
IN STOCK -
Methyl 3-Ethoxy-3-Methoxypropanoate
IN STOCK -
Maltol
IN STOCK -
4,4‘-Methylenebis(2,6-di-tert-butylphenol)
BACK ORDER -
Benzoic acid, 2-sulfino-, 1-methyl ester
CUSTOM SYNTHESIS -
Malathion
IN STOCK -
1-(Methylsulfonyl)cyclopropanemethanamine
CUSTOM SYNTHESIS -
Imatinib Mesylate Impurity 62
IN STOCK -
Montelukast Ketone
IN STOCK -
methyl 3-methylbenzenesulfonate
IN STOCK -
Melphalan D-Isomer
CUSTOM SYNTHESIS -
Meglumine Diatrizoate
BACK ORDER -
4`-Methyl[1,1`-biphenyl]-3-carbonitrile
CUSTOM SYNTHESIS -
Furfural Impurity 21
IN STOCK -
2-Methoxy-5-methylpyridine
IN STOCK -
Minocycline hydrochloride
IN STOCK -
O-Methyl Meloxicam
IN STOCK -
N-tert-Butylmethanimine
CUSTOM SYNTHESIS -
Monuron TCA
CUSTOM SYNTHESIS -
1,3-Diethylbenzene
IN STOCK -
Miriplatin
BACK ORDER -
2-Methyl-4,5-diphenyloxazole
IN STOCK
484,173 products · 8070 pages































![Chemical structure of 1-[5-(Methylsulfanyl)-1,3,4-oxadiazol-2-yl]-1-ethanamine hydrochloride](/structures/w4/HBZNTEYFNFZHEH-UHFFFAOYSA-N.webp?v=7)









![Chemical structure of 4`-Methyl[1,1`-biphenyl]-3-carbonitrile](/structures/w4/IDJXCGMHZMGQRV-UHFFFAOYSA-N.webp?v=7)







![Chemical structure of 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride](/structures/w4/MCMQMNPGKTYDDM-UHFFFAOYSA-N.webp?v=7)






